Loading clinical trials...
Loading clinical trials...
Economic Burden Associated With Nintedanib Non-adherence Among Medicare Beneficiaries With IPF
Conditions
Interventions
Nintedanib
Locations
1
United States
Medicus Economics, LCC
Milton, Massachusetts, United States
Start Date
May 16, 2023
Primary Completion Date
June 30, 2023
Completion Date
June 30, 2023
Last Updated
October 1, 2024
NCT06238622
NCT07299695
NCT07466420
NCT06241560
NCT07407543
NCT05989698
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions